Navigation Links
2 federal public health grants awarded to Weill Cornell Medical College
Date:1/16/2008

NEW YORK (Jan. 16, 2008) -- Two major federal grants have been awarded to Public Health faculty at Weill Cornell Medical College in New York City.

Dr. Kenneth W. Griffin is the recipient of a three-year $1.6 million NIH grant from the National Institute on Drug Abuse (NIDA) for research into the long-term effects of a school-based drug-abuse prevention program previously delivered to urban minority youth attending New York City middle schools. The study will focus on a sample of approximately 3,500 young adults, ages 21 to 23, who participated in a randomized prevention trial during their early teens. In addition to testing the long-term effects of the prevention program on alcohol, tobacco and illicit drug use among the participants as young adults, the study will test whether the effects generalize to a variety of sexual risk behaviors.

Dr. Griffin is associate professor of public health in the Division of Prevention and Health Behavior, Department of Public Health, Weill Cornell Medical College.

Dr. Inmaculada de Melo-Martn is the recipient of a two-year $150,000 National Science Foundation Grant (NSF) for innovative research examining the ways in which the concept of human dignity is used in current debates about contentious biotechnologies such as embryonic stem cell research, human genetic enhancement and the creation of human-nonhuman chimeras. It will provide the first systematic assessment of what several influential scholars and recent national and international science policy documents mean when they say that these technologies threaten human dignity. Thus, the research can play a role in improving dialogue between the sciences and the humanities, and between the sciences and society.

Dr. de Melo-Martn is associate professor of public health in the Division of Medical Ethics, Department of Public Health, Weill Cornell Medical College.

"These awards represent important acknowledgments of the societal val
'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. SNM applauds NAS study showing need to restore federal nuclear medicine research funding
2. NOAA proposes federal regulations to protect black abalone
3. How the public perceives biotech
4. Anthony S. Fauci awarded Lasker Award for Public Service
5. Folic acid lowers blood arsenic levels, according to Mailman School of Public Health study
6. BIO-key International Showcasing Innovative Public Safety Solutions at 2007 IACP Conference
7. Mandate for public access to NIH-funded research poised to become law
8. Market testing of dietary supplements and drugs underscores value of USPs public health programs
9. Asthma link to post-traumatic stress disorder, says Mailman School of Public Health study
10. Columbia researchers: Growth of CT scan use may lead to significant public health problem
11. Wireless Public Safety Solution From BIO-key(R) and DaProSystems Links Virginia Law Enforcement Agencies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...RK (November 24, 2009) -- The Wildlife Conservatio... that the last remaining population of Siberian ti...rising tide of poaching and habitat loss. , ...an officials of what needs to be done to protect r..., The report was released by the Sib...
(Date:11/23/2009)... presents strong evidence that the "synergistic" e...ic-related pollution and indoor endotoxin causes m... exposure alone. , Environmental health scient...of Medicine have shown that children exposed to bo...door endotoxin during early life are six times mor...
(Date:11/23/2009)... than 160 participants gathered this week for the ...TIATIVE conference. This year,s topic, "Synthetic ...and medical researchers to explore the engineering...erging field of synthetic biology. , Bonnie L. B...n University and this year,s conference chair, cha...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Majority of Public Maintains Support for Addressing Health Care Reform Now 52480 1Majority of Public Maintains Support for Addressing Health Care Reform Now 52480 2Majority of Public Maintains Support for Addressing Health Care Reform Now 52480 3Majority of Public Maintains Support for Addressing Health Care Reform Now 52480 4Majority of Public Maintains Support for Addressing Health Care Reform Now 52480 5KLOS 26 Red Cross Set to Rock SoCal With Massive 5 Day Blood Drive 52478 1KLOS 26 Red Cross Set to Rock SoCal With Massive 5 Day Blood Drive 52478 2KLOS 26 Red Cross Set to Rock SoCal With Massive 5 Day Blood Drive 52478 3E Cigarettes Pose a Health Hazard FDA Warns 52474 1E Cigarettes Pose a Health Hazard FDA Warns 52474 2E Cigarettes Pose a Health Hazard FDA Warns 52474 3
...rs at the UC Davis M.I.N.D. Institute has found th... children born in California with autism since 199... condition is diagnosed or counted and the trend ...ary 2009 issue of the journal Epidemiology , resu...ld shift from genetics to the host of chemicals an...
...nal that publishes original research contributions... of entomology, plant pathology, virology, nematol...gicides, herbicides and other biocides. Emphasis ...iseases. , Phytoparasitica also publishes invit...t editorials written by reputable scientists attes...
... Prevention Research , a journal of the American A...nts of black raspberries with chemopreventive pote...ive Cancer Center found that anthocyanins, a class...wth and stimulated apoptosis in the esophagus of r...r data provide strong evidence that anthocyanins a...
Other Biology News:Study shows California's autism increase not due to better counting, diagnosis 2Study shows California's autism increase not due to better counting, diagnosis 3Springer expands its portfolio in plant sciences with Phytoparasitica 2
(Date:11/24/2009)...re-FirstCall/--Sigma-AldrichCorporation(Nasdaq: SI...day,December1stat1:45PMGMTinLondon,7:45AMUS/CST.In...heInternetavailableat http://inve s tor.sig m ...toaccessthisfile. ,, AboutSigma-Aldrich: Sig...mpany.Itschemicalandbiochemicalproductsandkitsareu...
(Date:11/24/2009)...RNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ...ommercializingnovelpainmanagementtherapies,announc...veOfficer,isscheduledtopresentatthe21stAnnualPiper...09atTheNewYorkPalaceHotelinNewYork,NewYork. ,, ...r,willbeavailabletorespondtoquestionsduringthepres...
(Date:11/24/2009)...asbeenmetforpatientswithadvanced-stage,orrecurrent...wire-FirstCall/-AEternaZentarisInc.(NASDAQ: AEZS ;...panyfocusedonendocrinetherapyandoncology,todayanno...rgetedcytotoxicpeptideconjugate,AEZS-108(formerlyA...lcancer.Inapersonalizedhealthcareapproach,thestudy...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--GenomicHealth,Inc.(Nasdaq...,sExecutiveChairman,willpresentatthe21stAnnualPipe...,December1,2009at10:00a.m.ET. ,, Toaccesstheliv...isittheInvestorRelationssectionofGenomicHealth,swe...onnecttothewebsiteatleast15minutespriortothebeginn...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...FRANCISCO, March 12 VIA Pharmaceuticals, Inc. (Na... the development of compounds for the treatment of...nced it has entered into a $10.0 million secured n...llary agreements, the "Loan Agreement") with Bay C...s (collectively, "Lender"), the Company,s principa...
... A significant challenge utili... the cost and uncertainty associated with vectors ...roblem, DNA2.0 has developed a new family of vecto...s. pJexpress vectors are specifically engineered t...own to express better than comparable pET vectors....
...ADELPHIA, March 12 ERT, a leading provider of cen...ther services to the biopharmaceutical, medical de... it will be showcasing its portfolio of products a... DIA Euromeeting, 23-25 March 2009 in Berlin, Germ...ing sessions, which will discuss the impact of tec...
Other Biology Technology:VIA Pharmaceuticals Secures Financing Up to $10.0 Million 2VIA Pharmaceuticals Secures Financing Up to $10.0 Million 3VIA Pharmaceuticals Secures Financing Up to $10.0 Million 4DNA2.0 Introduces Freedom of Expression With a New Family of Bacterial Expression Vect:ors 2DNA2.0 Introduces Freedom of Expression With a New Family of Bacterial Expression Vect:ors 3ERT to Showcase Its Clinical Trials Portfolio at DIA's 21st Euromeeting 2ERT to Showcase Its Clinical Trials Portfolio at DIA's 21st Euromeeting 3
Uniblot accessories from Sigma-Aldrich
StemSep Anti-Human CD69 Tetramer, 200 uL from StemCell Technologies, Inc.
Aquarius 384 Multichannel Pipettor from Tecan
...nx software, a multitasking application capable of...amming and operation of lab automation workcells e...tom modification by programmers. • Users cr...wchart. If you can build a flowchart, you can writ...
Biology Products: